• Home
  • Market
  • Top 3 Stocks Under ₹100 to Buy This Monday: Sumeet Bagadia’s Expert Picks for April 28, 2025
Top 3 Stocks Under ₹100 to Buy This Monday: Sumeet Bagadia's Expert Picks for April 28, 2025

Top 3 Stocks Under ₹100 to Buy This Monday: Sumeet Bagadia’s Expert Picks for April 28, 2025

The Indian stock market has shown a steady recovery over the past week, marking a second consecutive week of gains for the domestic equity benchmarks. Although the overall weekly increase was modest, the Sensex and Nifty 50 managed to showcase resilience amid fluctuations. After an initial uplift, the indices traded within a narrow range before experiencing some profit-taking in the final trading session. Ultimately, the Nifty 50 index fell by 0.86% to 24,039.35, while the BSE Sensex saw a decline of 0.74%, settling at 79,212.53.

Market Trends and Technical Insights

The Nifty 50 index, despite facing some resistance, rose by 0.79%, marking its second consecutive weekly gain. This upward movement is significant as it has successfully closed above the psychological threshold of 24,000, which is a crucial technical level. Furthermore, the index remains positioned above the 21-day, 55-day, and 200-day exponential moving averages, indicating ongoing bullish sentiment in the market.

Expert Opinions on Market Sentiment

Sumeet Bagadia, the Executive Director at Choice Broking, expresses a cautious outlook regarding the Indian stock market. He mentions that the Nifty 50 has settled below the 200-day exponential moving average (DEMA) of 24,050, which may signal potential volatility ahead. Bagadia emphasizes the importance of a stock-specific strategy, noting, “The critical support for the benchmark index is at 23,800, which is likely to hold firm. Investors should focus on stocks that exhibit strength in their technical charts.”

Top Stock Picks Under ₹100

For those looking to invest in shares priced under ₹100, Sumeet Bagadia has identified three promising stocks:

  1. Shree Digvijay Cement Co

    • Current Price: ₹79.94
    • Stop Loss: ₹77.14
    • Target Price: ₹85.53
  2. Restaurant Brands Asia

    • Current Price: ₹82.22
    • Stop Loss: ₹79.34
    • Target Price: ₹88.00
  3. Lotus Eye Hospital and Institute
    • Current Price: ₹74.17
    • Stop Loss: ₹71.50
    • Target Price: ₹79.28
See also  Stock Market Update: IREDA and Birlasoft Join April 17 F&O Ban List – Discover the Top 5 Stocks Impacted!

Conclusion

As the market navigates through these cautious waters, investors should keep an eye on these recommended stocks under ₹100, which may offer potential upside. With a strategic approach and careful monitoring of market trends, there are opportunities for growth even in a fluctuating environment. Always consider market conditions and individual risk tolerance before making investment decisions.

Related Post

Rise and Shine: How Early Birds Boost Their Energy for Success!
Rise and Shine: How Early Birds Boost Their Energy for Success!
ByAbhinandanApr 28, 2025

Early reporting companies for the March quarter are facing margin pressures due to subdued demand…

10 Compelling Reasons Why Stock Market Dips Can Benefit Long-Term Investors: Insights from Geojit's Vinod Nair
10 Compelling Reasons Why Stock Market Dips Can Benefit Long-Term Investors: Insights from Geojit’s Vinod Nair
ByAbhinandanApr 27, 2025

Following recent tariff adjustments, the Indian stock market has surged 14% in two weeks, showcasing…

Wall Street Week Ahead: Key Insights on Q1 GDP, Jobs Data, PCE Inflation & Earnings from Apple, Microsoft, and Meta
Wall Street Week Ahead: Key Insights on Q1 GDP, Jobs Data, PCE Inflation & Earnings from Apple, Microsoft, and Meta
ByAbhinandanApr 27, 2025

Investors on Wall Street are preparing for a crucial week of economic data and quarterly…

Unlocking the Future: How Prediction Markets Empower You to Bet on Tomorrow's Outcomes
Unlocking the Future: How Prediction Markets Empower You to Bet on Tomorrow’s Outcomes
ByAbhinandanApr 27, 2025

In a world where predictions influence finance, politics, and public sentiment, experts often evade accountability…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!